| Mohamed Noormohideen, MD | |
|
500 Lauchwood Dr, Laurinburg, NC 28352-5501 | |
| (910) 291-6904 | |
| Not Available |
| Full Name | Mohamed Noormohideen |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 29 Years |
| Location | 500 Lauchwood Dr, Laurinburg, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780685842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2011-00464 (North Carolina) | Secondary |
| 207R00000X | Internal Medicine | 2011-00464 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Of Scotland County, Inc | Bennettsville, SC | Hospice |
| Scotland Memorial Hospital | Laurinburg, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scotland Regional Health Network | 2365573185 | 50 |
News Archive
A woman's risk of developing diabetes during pregnancy can be identified up to seven years before she becomes pregnant based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.
Shengtai Pharmaceutical, Inc. announced on August 6, 2010 that Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its operating subsidiary in China, entered into an agreement with Kelun Pharmaceutical ("Kelun") to supply Kelun with 10 thousand tons of dextrose monohydrate injection grade: Kelun Guizhou will be supplied with 7 hundred tons and Kelun Sichuan with 9.3 thousand tons. The agreement is entered into at reasonable prices and will be carried out by prepayments.
Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science, the findings indicate that treatments currently used for other conditions could also work for dry AMD.
Monash University and 60P Australia Pty Ltd, a subsidiary of 60° Pharmaceuticals LLC, have announced today an exclusive partnering deal, with 60P obtaining rights to develop the drug Fenretinide for dengue fever.
The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), Northwestern Medicine scientists have discovered.
› Verified 2 days ago
| Entity Name | Scotland Regional Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972829562 PECOS PAC ID: 2365573185 Enrollment ID: O20100623000242 |
News Archive
A woman's risk of developing diabetes during pregnancy can be identified up to seven years before she becomes pregnant based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.
Shengtai Pharmaceutical, Inc. announced on August 6, 2010 that Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its operating subsidiary in China, entered into an agreement with Kelun Pharmaceutical ("Kelun") to supply Kelun with 10 thousand tons of dextrose monohydrate injection grade: Kelun Guizhou will be supplied with 7 hundred tons and Kelun Sichuan with 9.3 thousand tons. The agreement is entered into at reasonable prices and will be carried out by prepayments.
Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science, the findings indicate that treatments currently used for other conditions could also work for dry AMD.
Monash University and 60P Australia Pty Ltd, a subsidiary of 60° Pharmaceuticals LLC, have announced today an exclusive partnering deal, with 60P obtaining rights to develop the drug Fenretinide for dengue fever.
The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), Northwestern Medicine scientists have discovered.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohamed Noormohideen, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Mohamed Noormohideen, MD 500 Lauchwood Dr, Laurinburg, NC 28352-5501 Ph: (910) 291-6904 |
News Archive
A woman's risk of developing diabetes during pregnancy can be identified up to seven years before she becomes pregnant based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.
Shengtai Pharmaceutical, Inc. announced on August 6, 2010 that Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its operating subsidiary in China, entered into an agreement with Kelun Pharmaceutical ("Kelun") to supply Kelun with 10 thousand tons of dextrose monohydrate injection grade: Kelun Guizhou will be supplied with 7 hundred tons and Kelun Sichuan with 9.3 thousand tons. The agreement is entered into at reasonable prices and will be carried out by prepayments.
Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science, the findings indicate that treatments currently used for other conditions could also work for dry AMD.
Monash University and 60P Australia Pty Ltd, a subsidiary of 60° Pharmaceuticals LLC, have announced today an exclusive partnering deal, with 60P obtaining rights to develop the drug Fenretinide for dengue fever.
The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), Northwestern Medicine scientists have discovered.
› Verified 2 days ago
Brian Dalrymple, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Lauchwood Dr, Laurinburg, NC 28352 Phone: 910-291-6904 | |
Dr. Habiba Tunau, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 612 S Main St, Laurinburg, NC 28352 Phone: 910-266-0062 Fax: 910-277-9208 | |
Elaine A Staten, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 E Lauchwood Dr, Laurinburg, NC 28352 Phone: 910-291-7000 | |
Dr. Jonathan Nestor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E Launchwood Dr, Laurinburg, NC 28352 Phone: 910-276-7727 Fax: 910-277-7439 | |
Dr. Deborah White Greimel, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1708 Hwy 401 South, Laurinburg, NC 28352 Phone: 910-291-0903 Fax: 910-291-0978 | |
Dr. Matthew Block, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Medical Dr, Laurinburg, NC 28352 Phone: 910-277-7858 Fax: 910-277-8286 | |
Daniel Fernandez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Lauchwood Dr, Laurinburg, NC 28352 Phone: 910-291-6904 |